Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Titel:
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Auteur:
Machiels, Jean-Pascal Tao, Yungan Licitra, Lisa Burtness, Barbara Tahara, Makoto Rischin, Danny Alves, Gustavo Lima, Iane Pinto Figueiredo Hughes, Brett G M Pointreau, Yoann Aksoy, Sercan Laban, Simon Greil, Richard Burian, Martin Hetnał, Marcin Delord, Jean-Pierre Mesía, Ricard Taberna, Miren Waldron, John N Simon, Christian Grégoire, Vincent Harrington, Kevin J Swaby, Ramona F Zhang, Yayan Gumuscu, Burak Bidadi, Behzad Siu, Lillian L